Mariana Matias is graduated in Pharmaceutical Sciences since 2011 and PhD at the University of Beira Interior since 2018. Her PhD thesis, entitled “Development of new antiepileptic drug candidates: a set of lamotrigine-related compounds”, was supported by the Fundação para a Ciência e Tecnologia (FCT) as a PhD fellowship. Currently, Mariana is a Post-Doctoral Researcher (project supported by FCT entitled “Nanoformulated hybrid molecules for specific targeting melanoma metastasis”) at the Research Institute for Medicines (iMed.ULisboa), integrated in the Faculty of Pharmacy of the University of Lisbon. In the scope of this project, the research work titled “Validation of a new nanotechnological approach for the treatment of melanoma metastasis using primary cells from IPO patients” was granted by the Ordem dos Farmacêuticos. Over the years, her main scientific interests have been Pharmaceutical and Medicinal Chemistry, Pharmaco-toxicology and Nanotechnology and has been mainly working on the design, chemical synthesis and biological evaluation and nanoformulation of different heterocyclic compounds. Mariana published several papers in peer-reviewed journals and book chapters and was authored/co-authored several communications at scientific meetings (9 oral communications and 19 poster presentations). She co-supervised several students and has participated as voluntary professor in curricular units of Pharmaceutical Sciences and Medicinal Chemistry courses at the University of Beira Interior.